
Aurobindo Pharma gets USFDA approval for Glycerol Phenylbutyrate oral liquid
Aurobindo Pharma gets USFDA nod for Glycerol Phenylbutyrate Oral Liquid for urea cycle disorders, to launch from Unit III, US market about 50.2 million dollars,…

Aurobindo Pharma gets USFDA nod for Glycerol Phenylbutyrate Oral Liquid for urea cycle disorders, to launch from Unit III, US market about 50.2 million dollars,…

Sanjeev Prasad, Managing Director and Co-Head at Kotak Institutional Equities, pointed out that markets such as Taiwan and Korea are witnessing strong earnings growth, supported…

Siddhartha Khemka, Head of Research, Wealth Management at Motilal Oswal Financial Services, highlighted mixed sector trends, with caution on discretionary and select stocks, while maintaining…

Citi study finds a 5% allocation split between gold and bitcoin boosts portfolio efficiency versus a traditional 60/40 mix, with bitcoin outperforming gold recently.

Citi said that Angel One’s growth was driven by higher trading volumes, with trading orders rising 31% year-on-year and 13% from the December quarter, while…

At the current price, shares of Bharat Wire Ropes are trading at 10 times enterprise value to EBITDA (EV / EBITDA), and 17 times its…

NBCC emerges top bidder to buy a 2.8 lakh square feet commercial tower at Bharat Business Park in Delhi for about ₹1,374 crore, plans self…

For the quarter that ended on December 31, 2025, promoters of Hyundai Motor India still had a 82.5% stake in the company, higher than the…

In the near term, however, Dixon Tech is likely to face pressure on volumes and margins over the next 2-3 quarters due to higher input…

James Knightley, Chief International Economist at ING, suggests that even if geopolitical tensions ease, the energy shock will persist for several months, with implications for…